Pretransplantation Evaluation: Pulmonary, Cardiac, and Renal

Transplantation of the Liver

Volumn , Issue , 2005, Pages 405-427

  Mai, Martin L ^a,b   Yip, Daniel S ^a,c   Keller, Cesar A ^a,b   Gonwa, Thomas A ^a,c,d  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c St Luke's Hospital Jacksonville   (United States)

^d Kidney Pancreas Transplantation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67449089084     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0118-2.50033-1     Document Type: Chapter

References (184)

1. DH VanThiel, RR Schade, JS Gavaler, et al. (1984) Medical aspects of liver transplantation. Hepatology 4 S79-S83.
2. RW Busuttil, LI Goldstein, GM Danovitch, et al. (1986) Liver transplantation today. Ann Intern Med 104 377-389.
3. JP Donovan, RK Zetterman, DA Burnett and MF Sorrell (1989) Preoperative evaluation, preparation, and timing of orthotopic liver transplantation in the adult. Semin Liver Dis 9 168-175.
4. MJ Krowka and DA Cortese (1989) Pulmonary aspects of liver disease and liver transplantation. Clin Chest Med 10 593-616.
5. AD Siefka and GA Lillington (1987) Pulmonary complications of surgery. RJ Bolt (Eds) Medical Evaluation of the Surgical Patient Mount Kisco, NY: Futura Publishing 307-326.
6. CA Powell and C Caplan (2001) Pulmonary function tests in preoperative pulmonary evaluation. Clin Chest Med 22 703-714.
7. FA McAlister, NA Khan, SE Straus, et al. (2003) Accuracy of the preoperative assessment in predicting pulmonary risk after nonthoracic surgery. Am J Respir Crit Care Med 167 741-744.
8. KN Lazaridis, JW Frank, MJ Krowka, et al. (1999) Hepatic hydrothorax: Pathogenesis, diagnosis and management. Am J Med 107 262-267.
9. RM Strauss and TD Boyer (1997) Hepatic hydrothorax. Semin Liver Dis 17 227-232.
10. WH Abelman, NR Frank, EA Gaensler and DN Cugell (1954) Effects of abdominal distention by ascites on lung volumes and ventilation. Arch Intern Med 93 528-540.
11. MT Krowka and DA Cortese (1985) Pulmonary aspects of chronic liver disease and liver transplantation. Mayo Clin Proc 60 407-418.
12. FL Lieberman, R Hidemura, RL Peters, et al. (1966) Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Int Med 64 341-351.
13. WM Albers, AJ Salem, DA Salomon, et al. (1991) Hepatic hydrothorax. Cause and management. Arch Intern Med 151 2383-2388.
14. RM Strauss and TD Boyer (1997) Hepatic hydrothorax. Semin Liver Dis 17 227-232.
15. D Rubinstein, IE McInnes and FJ Dudley (1985) Hepatic hydrothorax in the absence of clinical ascites: Diagnosis and management. Gastroenterology 88 188-191.
16. J Castellote, J Gornals, C Lopez and X Xiol (2002) Acute tension hydrothorax: A life-threatening complication of cirrhosis. J Clin Gastroenterol 34 588-589.
17. X Xiol, JM Castellvi, J Guardiola, et al. (1996) Spontaneous bacterial empyema in cirrhotic patients: A prospective study. Hepatology 23 719-723.
18. SA Sahn (1988) State of the art: The pleura. Am Rev Respir Dis 138 184-234.
19. BA Runyon, M Greenblatt and RH Mingh (1986) Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 81 566-567.
20. J Moroux, C Perrin, N Venissac, et al. (1996) Management of pleural effusion of cirrhotic origin. Chest 109 1093-1096.
21. E Ghandour, J Carter, M Feola, et al. (1990) Management of hepatic hydrothorax with peritoneovenous shunt. South Med J 83 718-719.
22. RM Strauss, LG Martin, SL Kaufman and TD Boyer (1994) Transjugular intrahepatic portosystemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 89 1520-1522.
23. P Berthelot, JG Walker, S Sherlock and L Reid (1966) Arterial changes in the lungs in cirrhosis of the liver—lung spider nevi. N Engl J Med 274 291-298.
24. MJ Krowka and DA Cortese (1990) Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation. Hepatology 11 138-142.
25. MJ Krowka, ER Dickson and DA Cortese (1993) Hepatopulmonary syndrome: Clinical observations and lack of therapeutic response to somatostatin analogue. Chest 104 515-521.
26. MJ Krowka, GA Wiseman, OL Burnet, et al. (2000) Hepatopulmonary syndrome: A prospective study of relationships between severity of liver disease, PaO2, response to 100% oxygen and brain uptake after 99TC MAA lung scanning. Chest 118 615-624.
27. P Schenk, V Fuhrman, C Madl, et al. (2002) Hepatopulmonary syndrome: Prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 51 853-859.
28. R Aller, JL Moya, V Moreira, et al. (1999) Diagnosis of hepatopulmonary syndrome with contrast transesophageal echocardiography: Advantages over contrast transthoracic echocardiography. Dig Dis Sci 44 1243-1248.
29. MJ Krowka, J Tajik, ER Dickson, et al. (1990) Intrapulmonary vascular dilatations (IVPD) in liver transplant candidates: Screening by two-dimensional contrast-enhanced echocardiography. Chest 97 465-470.
30. WE Hopkins, AD Waggoner and B Barzilai (1992) Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. Am J Cardiol 70 516-519.
31. ES Edell, DA Cortese, MT Krowka and K Rehder (1989) Severe hypoxemia and liver disease. Am Rev Respir Dis 140 1631-1635.
32. HH Davis, DJ Schwartz, SS Lefrak, et al. (1978) Alveolar-capillary oxygen disequilibrium in hepatic cirrhosis. Chest 73 507-511.
33. ER Bank, JH Thrall and DR Dantzker (1983) Radionuclide demonstration of intrapulmonary shunting in cirrhosis. Am J Roentgenol 140 967-969.
34. JK Stoller, D Moodie, WA Schiavone, et al. (1990) Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation. Hepatology 11 54-58.
35. JK Stoller (1990) As the liver goes, so goes the lung. Chest 97 1028-1029.
36. MJ Krowka (2001) Caveats concerning hepatopulmonary syndrome (editorial). J Hepatol 34 756-758.
37. MT Krowka and DA Cortese (1987) Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate. Mayo Clin Proc 62 164-173.
38. Lange PA, Stoller JK: Hepatopulmonary syndrome. UpToDate online: Available at www.uptodate.com keywords: “hepatopulmonary syndrome.”
39. MJ Krowka (2000) Hepatopulmonary syndromes. Gut 46 1-4.
40. MB Fallon, GA Abrams, JW McGrath, et al. (1997) Common bile duct ligation in the rat: A model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J Physiol 272 G779-G784.
41. H Nunes, D Lebrec, M Mazmaninan, et al. (2001) Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 164 879-885.
42. R Wiest, S Das, G Garcia-Tsao, et al. (1999) Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric contractility. J Clin Invest 104 1223-1233.
43. JV Reynolds, P Murchan, N Leonard, et al. (1996) Gut barrier failure in experimental jaundice. J Surg Res 62 11-16.
44. RJ Panos and SK Backer (1996) Mediators, cytokines and growth factors in liver-lung interactions. Clin Chest Med 17 151-169.
45. A Rabiller, H Nunes, D Lebrec, et al. (2002) Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 166 514-517.
46. TE Starzl, CG Groth, L Brattschneider, et al. (1968) Extended survival in three cases of orthotopic homo transplantation of the human liver. Surgery 63 549.
47. LS Eriksson, C Söderman, B Ericzon, et al. (1990) Normalization of ventilation/perfusion relationship after liver transplantation in patients with decompensated cirrhosis: Evidence for a hepatopulmonary syndrome. Hepatology 12 1350.
48. RM Anel and JN Sheagren (2001) Novel presentation and approach to management of hepatopulmonary syndrome with use of antimicrobial agents. Clin Infect Dis 32 E131-E136.
49. MJ Krowka, MK Porayko and DJ Plevak (1997) Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation. Case reports and literature review. Mayo Clin Proc 72 44-53.
50. MR Arguedas, GA Abrams, MJ Krowka and MB Fallon (2003) Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 37 192-197.
51. SE Battaglia, JJ Pretto, LB Irving, et al. (1997) Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation. Hepatology 25 1228.
52. IO Colle, R Moreau, E Godinho, et al. (2003) Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study. Hepatology 37 401-409.
53. L Jiang, SE Wiegers and AE Weyman (1994) Right ventricle. AE Weymen (Eds) Principles and practice of echocardiography 2nd ed. Philadelphia: Lea & Febiger 901-902.
54. K Swanson and M Krowka (2002) Arterial oxygenation associated with portopulmonary hypertension. Chest 121 1869-1875.
55. P Kuo, J Plotkin, G Sean, et al. (1999) Portopulmonary hypertension and the liver transplant candidate. Transplantation 67 1087-1093.
56. MAE Ramsay, BR Simpson, AT Nguyen, et al. (1997) Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 3 494-500.
57. BS Edwards, EK Weir, WD Edwards, et al. (1987) Coexistent pulmonary and portal hypertension: Morphological and clinical features. J Am Coll Cardiol 10 1233-1238.
58. F Jones, PC Kuo, LB Johnson, et al. (1999) The coexistence of portopulmonary hypertension and hepatopulmonary syndrome. Anesthesiology 90 626-629.
59. MD Kaspar, MAE Ramsay, CB Shuey, et al. (1998) Severe pulmonary hypertension and amelioration of hepatopulmonary syndrome after liver transplantation. Liver Transpl Surg 4 177-179.
60. RJ Barst, LJ Rubin, WA Long, et al. (1998) A comparison of continuous intravenous epoprostenol with conventional therapy for primary pulmonary hypertension. N Engl J Med 334 296.
61. V McLaughlin, D Genthner, M Panella, et al. (1998) Reduction in pulmonary vascular resistance with long-term epoprostenol therapy in primary pulmonary hypertension. N Engl J Med 338 273.
62. G Martinez-Palli, JA Barbera, P Taura, et al. (1999) Severe portopulmonary hypertension after liver transplantation in a patient with preexistent hepatopulmonary syndrome. J Hepatol 31 1075-1079.
63. MJ Krowka, RP Frantz, MD McGoon, et al. (1999) Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 30 641-648.
64. MAE Ramsay, A Schmidt, HAT Hien, et al. (1997) Nitric oxide does not reverse pulmonary hypertension associated with end-stage liver disease: A preliminary report. Hepatology 25 524-527.
65. D Plevak, M Krowka, S Rettke, et al. (1993) Successful liver transplantation in patients with mild to moderate pulmonary hypertension. Transplant Proc 25 1840.
66. AM DeWolf, T Gasior and Y Kang (1991) Pulmonary hypertension in a patient undergoing liver transplant. Transplant Proc 23 2000-2001.
67. MJ Krowka, DJ Plevak, JY Findlay, et al. (2000) Pulmonary hemodynamics and perioperative cardiopulmonary related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 6 443-450.
68. EP Molmenti, M Ramsay, K Lynch, et al. (2001) Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation. Transplant Proc 33 1332.
69. MAE Ramsay, BR Simpson, KJ Nguyen, et al. (1997) Nitric oxide does not reverse pulmonary hypertension associated with end stage liver disease: A preliminary report. Hepatology 25 254.
70. MAE Ramsay, C Spikes, CA East, et al. (1999) The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol. Anesthesiology 90 299-301.
71. AP Fishman (Ed.) (1988) Pulmonary Hypertension and Cor Pulmonale, Pulmonary Diseases and Disorders New York: McGraw-Hill
72. R Rodriguez-Roisin, A Pares, M Bruguera, et al. (1981) Pulmonary involvement in primary biliary cirrhosis. Thorax 36 208-212.
73. P Uddenfeldt, P Bjerle, A Danielsson, et al. (1988) Lung function abnormalities in patients with primary biliary cirrhosis. Acta Med Scand 223 549-555.
74. DG James and WJ Williams (1985) Sarcoidosis and other granulomatous disorders Philadelphia: WB Saunders 144-148.
75. R Francavilla, S Castellaneta, N Hadzic, et al. (2000) Prognosis of alpha-1 antitrypsin deficiency-related liver disease in the era of paediatric liver transplantation. J Hepatol 32 986-992.
76. EC Lai, FT Kao, ML Law, et al. (1983) Assignment of the alpha 1 antitrypsin gene and sequence-related gene to human chromosome 14 by molecular hybridization. Am J Hum Genet 35 385-392.
77. ML Brantley, LD Paul, BN Miller, et al. (1988) Clinical features and alpha 1 antitrypsin deficiency of adults with symptoms. Am Rev Respir Dis 138 327-336.
78. RG Crystal, ML Brantly, RC Hubbard, et al. (1989) The alpha 1-antitrypsin gene and its mutations. Chest 95 196-208.
79. Alpha-1-Antitrypsin Deficiency Registry Study Group (1998) Survival and FEV1 decline in individuals with severe deficiency of alpha-1-antitrypsin. Am J Respir Crit Care Med 158 49-59.
80. American Thoracic Society (1989) Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. Am Rev Respir Dis 140 1494-1497.
81. CD Mullins, X Huang, S Merchant, et al. (2001) The direct medical costs of alpha(1) antitrypsin deficiency. Chest 119 745-752.
82. JM Hood, LJ Koep, RL Peters, et al. (1980) Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med 302 272-275.
83. JD Cooper, GA Patterson, R Grossman and J Maurer (1989) Double-lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis 139 303-307.
84. R Francavilla, SP Castellaneta, N Hadzic, et al. (2000) Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantation. J Hepatol 32 986-992.
85. GA Patterson, JR Maurer, TJ Williams, et al. (1991) Comparison of outcomes of double and single lung transplantation for obstructive lung disease. J Thorac Cardiovasc Surg 101 623-631.
86. RE Wood, TF Boat and CF Doershuk (1976) Cystic fibrosis. Am Rev Respir Dis 113 833-878.
87. KM Hayllar, SG Williams, AE Wise, et al. (1997) A prognostic model for the prediction of survival in cystic fibrosis. Thorax 52 313-317.
88. R Scott-Jupp, M Lama and MS Taenner (1991) Prevalence of liver disease in cystic fibrosis. Arch Dis Child 66 690-701.
89. P Milkiewicz, G Skiba, D Kelly, et al. (2002) Transplantation for cystic fibrosis: Outcome following early liver transplantation. J Gastroenterol Hepatol 17 208-213.
90. JP Couetil, O Soubrane, DP Houssin, et al. (1997) Combined heart-lung-liver, double-lung-liver and isolated liver transplantation for cystic fibrosis in children. Transpl Int 10 33-39.
91. J Marquez, D Martin, MA Virji, et al. (1986) Cardiovascular depression secondary to ionic hypocalcemia during hepatic transplantation in humans. Anesthesiology 65 457-461.
92. S Aggarwal, Y Kang, JA Freeman, et al. (1987) Postreperfusion syndrome: Cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 19(suppl 3), 54-55.
93. AM DeWolf (1991) Does ventricular dysfunction occur during liver transplantation? Transplant Proc 23 1922-1923.
94. JL Lichtor (1991) Ventricular dysfunction does occur during liver transplantation. Transplant Proc 23 1924-1926.
95. A DeWolf, T Gasior, B Begliomini, et al. (1990) Right ventricular function during orthotopic liver transplantation. Anesthesiology 73 A97.
96. WD Carey, JA Dumot, RR Pimentel, et al. (1995) The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 59 859-864.
97. JS Plotkin, RM Benitez, PC Kuo, et al. (1998) Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transplant Surg 4 253-257.
98. JS Plotkin, VL Scott, A Pinna, et al. (1996) Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 2 426-430.
99. A Urbano-Marquez, R Estruch, F Navarro-Lopez, et al. (1989) The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 320 409-419.
100. A Dabestani, JS Child, E Henze, et al. (1984) Primary hemachromatosis: Anatomic and physiological characteristics of the cardiac ventricles and their response to phlebotomy. Am J Cardiol 54 153.
101. KM Eagle, PB Berger, H Calkins, et al. (2002) ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—Executive summary. J Am Coll Cardiol 39 542-553.
102. L Younis, H Stratmann, B Takase, et al. (1994) Preoperative clinical assessment and dipyridamole thallium-201 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease. Am J Cardiol 74 311-317.
103. DD Miller, LT Younis, BR Chaitman, et al. (1997) Diagnostic accuracy of dipyridamole technetium 99m-labeled sestamibi myocardial tomography for detection of coronary artery disease. J Nucl Cardiol 4 18-24.
104. MK Das, PA Pellikka, DW Mahoney, et al. (2000) Assessment of cardiac risk before nonvascular surgery. J Am Coll Cardiol 35 1647-1653.
105. AJ McNeill, PM Fioretti and EM El-Said (1992) Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 70 41-46.
106. CL Donovan, PA Marcovitz, JD Punch, et al. (1996) Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 61 1180-1188.
107. AJ Schwartz and FA Hensley (1995) Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation. J Cardiothorac Vas Anesth 9 322-332.
108. JF Markmann, JW Markmann, DA Markmann, et al. (2001) Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 72 1113-1122.
109. S Nair, S Verma and PJ Thuluvath (2002) Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35 1179-1185.
110. TA Gonwa, ML Mai, LB Melton, et al. (2001) End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy. Transplantation 72 1934-1939.
111. TA Gonwa, ML Mai, LB Melton, et al. (2001) Renal replacement therapy and orthotopic liver transplantation: The role of continuous veno-venous hemodialysis. Transplantation 71 1424-1428.
112. CL Davis, TA Gonwa and AH Wilkinson (2002) Identification of patients best suited for combined liver-kidney transplantation: Part II. Liver Transpl 8 193-211.
113. MAJ Moser (2002) Options for induction immunosuppression in liver transplant recipients. Drugs 62 995-1011.
114. HJ Milionis and MS Elisaf (1999) Acid-base abnormalities in a patient with hepatic cirrhosis. Nephrol Dial Transplant 14 1599-1601.
115. H Prytz and AC Thomsen (1976) Acid-base status in liver cirrhosis. Disturbances in stable, terminal and portal-caval shunted patients. Scand J Gastroenterol 11 249-256.
116. SJ Lustik, AK Chhibber, JW Kolano, et al. (1997) The hyperventilation of cirrhosis: Progesterone and estradiol effects. Hepatology 25 55-58.
117. WT Merritt (2000) Metabolism and liver transplantation: Review of perioperative issues. Liver Transpl 6(supp 1), S76-S84.
118. JR Oster and GO Perez (1986) Acid-base disturbances in liver disease. J Hepatol 2 299-306.
119. JR Toblli, J Findor, J Sorda, et al. (1993) Latent distal renal tubular acidosis (dRTA) in primary biliary cirrhosis (PBC) and chronic autoimmune hepatitis (CAH). Acta Gastroenterol Latinoam 23 235-238.
120. DM Wilson and NP Goldstein (1974) Bicarbonate excretion in Wilson's disease (hepatolenticular degeneration). Mayo Clin Proc 49 394-400.
121. PA Gabow, S Moore and RW Schrier (1979) Spironolactone-induced hyperchloremic acidosis in cirrhosis. Ann Intern Med 90 338-340.
122. ER Eaves and MG Korman (1984) Cholestyramine-induced hyperchloremic metabolic acidosis. Aust N Z J Med 14 670-672.
123. Post TW, Rose BD: Approach to the adult with metabolic acidosis. UpToDate Online, version 11.1, www.uptodate.com 2001.
124. G Borroni, A Maggi, A Sangiovanni, et al. (2000) Clinical relevance of hyponatremia for the hospital outcome of cirrhotic patients. Dig Liver Dis 32 605-610.
125. P Gross, R Wehrle and E Bussemaker (1996) Hyponatremia: Pathophysiology, differential diagnosis and new aspects of treatment. Clin Nephrol 46 273-276.
126. RH Sterns (1987) Severe symptomatic hyponatremia: Treatment and outcome. A study of 64 cases. Ann Intern Med 107 656-664.
127. RH Sterns, JD Cappuccio, SM Silver, et al. (1994) Neurological sequelae after treatment of severe hyponatremia: A multicenter perspective. J Am Soc Nephrol 4 1522-1530.
128. P Gines and W Jimenez (1996) Aquaretic agents: A new potential treatment of dilutional hyponatremia in cirrhosis. J Hepatol 24 506-512.
129. BD Rose and TW Post (2001) Clinical Physiology of Acid-Base and Electrolyte Disorders 5th ed. New York: McGraw-Hill 898-910. pp 192–196, 383–396
130. P Castellino, MJ Bia and RA DeFronzo (1990) Adrenergic modulation of potassium metabolism in uremia. Kidney Int 37 793-798.
131. H Schepkens, R Vanholder, J Billiouw, et al. (2001) Life-threatening hyperkalemia using combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: An analysis of 25 cases. Am J Med 15 438-441.
132. MA Papadakis and AL Arieff (1987) Unpredictability of clinical evaluation of renal function in cirrhosis. Am J Med 82 945-952.
133. GR Gecelter and CM Comer (1995) Nutritional support during liver failure. Crit Care Clin 11 675-683.
134. AS Levey (1990) Measurement of renal function in chronic renal disease. Kidney Int 38 167-184.
135. L Roy, L Legault and G Pomier-Layrargues (1998) Glomerular filtration rate measurement in cirrhotic patients with renal failure. Clin Nephrol 50 342-346.
136. DS Sherman, DN Fish and I Teitelbaum (2003) Assessing renal function in cirrhotic patients: Problems and pitfalls. Am J Kidney Dis 41 269-278.
137. DN Amarapurkar, P Dhawan and RH Kalro (1994) Role of routine estimation of creatinine clearance in patients with liver cirrhosis. Indian J Gastroenterol 13 79-82.
138. R Orlando, M Mussap, M Plebani, et al. (2002) Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 48 850-858.
139. S Demirtas, A Bozbas, A Akbay, et al. (2001) Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta 311 81-89.
140. AS Levey, JP Bosch, JB Lewis, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine. A new prediction equation. Ann Intern Med 130 461-470.
141. BJ Nankivell, SM Gruenewald, RDM Allen, et al. (1995) Predicting glomerular filtration rate after kidney transplantation. Transplantation 59 1683-1689.
142. RD Perrone, TI Steinman, GJ Beck, et al. (1990) Utilization of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc – DTPA and inulin. Am J Kidney Dis 16 224-235.
143. DM Wilson, JH Bergert, TS Larson, et al. (1997) GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kidney Dis 30 646-652.
144. F Gaspari, N Perico and G Remuzzi (1998) Application of newer clearance techniques for the determination of glomerular filtration rate. Curr Opin Nephrol Hypertension 7 675-680.
145. F Wong and L Blendis (2001) New challenge of hepatorenal syndrome: Prevention and treatment. Hepatology 34 1242-1251.
146. L Spahr, JP Villeneuve, HK Tran, et al. (2001) Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites. Hepatology 33 28-31.
147. H Suzuki and AJ Stanley (2001) Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome. QJM 94 293-300.
148. HD Humes (1988) Aminoglycoside nephrotoxicity. Kidney Int 33 900-911.
149. RA Branch (1988) Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation. Arch Intern Med 148 2389-2394.
150. D Russo, R Minutolo, B Cianciaruso, et al. (1995) Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6 1451-1458.
151. MJ Dunn (2000) Are COX-2 selective inhibitors nephrotoxic? Am J Kid Dis 35 976-977.
152. GV Warren, SM Korbet, MM Schwartz, et al. (1989) Minimal change glomerulopathy associated with nonsteroidal anti-inflammatory drugs. Am J Kidney Dis 13 127-130.
153. V Arroyo, P Gines, A Gerbes, et al. (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23 164-176.
154. A Gines, A Escorsell, P Gines, et al. (1993) Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105 229-236.
155. MH Koppel, JM Coburn, MM Mims, et al. (1969) Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. New Engl J Med 280 1367-1371.
156. L Dagher and K Moore (2001) The hepatorenal syndrome. Gut 49 729-737.
157. A Cardenas, J Uriz, P Gines, et al. (2000) Hepatorenal syndrome. Liver Transpl 6(supp 1), S63-S71.
158. R Bataller, P Gines, V Arroyo, et al. (2000) Hepatorenal syndrome. Clin Liv Dis 4 487-507.
159. AE Briglia and FA Anania (2002) Hepatorenal syndrome: Definition, pathophysiology, and intervention. Crit Care Clin 18 345-373.
160. M Guevara, P Gines, G Fernandez-Esparrach, et al. (1998) Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27 35-41.
161. N Ganne-Carrie, A Hadengue, P Mathurin, et al. (1996) Hepatorenal syndrome: Long-term treatment with terlipressin as a bridge to liver transplantation. Dig Dis Sci 41 1054-1056.
162. R Moreau, F Durand, T Poynard, et al. (2002) Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study. Gastroenterology 122 923-930.
163. C Halimi, P Bonnard, B Bernard, et al. (2002) Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: Results of a multicentre pilot study. Eur J Gastroenterol Hepatol 14 153-158.
164. C Duvoux, D Zanditenas, C Hezode, et al. (2002) Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study. Hepatology 36 374-380.
165. P Angeli, R Volpin, G Gerunda, et al. (1999) Reversal of type 1 hepatorenal syndrome with administration of midodrine and octreotide. Hepatology 29 1690-1697.
166. S Holt, D Goodier, R Marley, et al. (1999) Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet 353 294-295.
167. CP Soper, AB Latif and MR Bending (1996) Amelioration of hepatorenal syndrome with selective endothelin-A antagonist. Lancet 347 1842-1843.
168. L Dagher, D Patch, R Marley, et al. (2000) Review article: Pharmacological treatment of the hepatorenal syndrome in cirrhotic patients. Aliment Pharmacol Ther 14 515-521.
169. KA Brensing, J Textor, J Perz, et al. (2000) Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study. Gut 47 288-295.
170. SR Mitzner, J Stange, S Klammt, et al. (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl 6 277-286.
171. KU Eckhardt (1999) Renal failure in liver disease. Intensive Care Med 25 5-14.
172. R Vanholder, W Van Biesen and N Lameire (2001) What is the renal replacement method of first choice for intensive care patients? J Am Soc Nephrol 12(Suppl 17), S40-S43.
173. ML Esson and RW Schrier (2002) Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 137 744-752.
174. S Zarich, LS Fang and JR Diamond (1985) Fractional excretion of sodium. Exceptions to its diagnostic value. Arch Intern Med 145 108-112.
175. SD Schlessinger, MR Tankersley and JJ Curtis (1994) Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis 23 655-660.
176. United States Renal Data System. (2000) Excerpts from the USRDS 2000 annual data report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 36(Supp 2), S1.
177. CL Davis, TA Gonwa and AH Wilkinson (2002) Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I. Liver Transpl 8 91-109.
178. F Wong (2002) Liver and kidney diseases. Clin Liver Dis 6 981-1011.
179. GB DiBelgiojoso, F Ferrario and N Landriani (2002) Virus related glomerular diseases: Histological and clinical aspects. J Nephrol 15 469-479.
180. IH Altraif, AS Abdulla, MI al Sebayel, et al. (1995) Hepatitis C associated glomerulonephritis. Am J Nephrol 15 407-410.
181. I Os, F Skjorten, C Svalander, et al. (1997) Alpha-1-antitrypsin deficiency associated with hepatic cirrhosis and IgA nephritis. Nephron 77 235-237.
182. T Komatsu, K Utsunomiya and T Oyaizu (1998) Goodpasture's syndrome associated with primary biliary cirrhosis. Intern Med 37 611-613.
183. S Emre, G Gondolesi, K Polat, et al. (2001) Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 7 220-225.
184. DR Nelson, C Soldevila-Pico, A Reed, et al. (2001) Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation. Liver Transpl 7 1064-1070.